drugset / Trial / NCT02758522

NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens

NCT02758522

Phase 4 Completed 105 enrolled Hospital Universitario Dr. Jose E. Gonzalez
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to compare the therapeutic efficacy of three regimens of insulin NPH/fast for optimal glycemic control in non-critical hospitalized patients.

Timeline

Start
2013-10
Primary completion
2015-10
Completion
2015-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 0.12 iu/kg Subcutaneous
Comparator Insulin Protein / enzyme biologic 0.16 iu/kg Subcutaneous
Comparator Insulin Protein / enzyme biologic 0.18 iu/kg Subcutaneous
Comparator Insulin Protein / enzyme biologic 0.2 iu/kg Subcutaneous
Comparator Insulin Protein / enzyme biologic 0.24 iu/kg Subcutaneous
Comparator Insulin Protein / enzyme biologic 0.3 iu/kg Subcutaneous
Comparator Insulin Protein / enzyme biologic 0.36 iu/kg Subcutaneous